BNP Paribas Financial Markets’s Zomedica Corp. ZOM Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-225	Closed	-$54	–	4338
2020 Q2	$54	Hold	225	–	–	﹤0.01%	4226
2020 Q1	$43	Hold	225	–	–	﹤0.01%	4242
2019 Q4	$74	Sell	225 -5,229	-96%	-$1.76K	﹤0.01%	4342
2019 Q3	$2.03K	Hold	5,454	–	–	﹤0.01%	4359
2019 Q2	$1.25K	Sell	5,454 -4,313	-44%	-$1.31K	﹤0.01%	4356
2019 Q1	$3.42K	Buy	9,767 +9,097	+1,358%	+$8.03K	﹤0.01%	4096
2018 Q4	$824	Sell	670 -620	-48%	-$983	﹤0.01%	3948
2018 Q3	$2.41K	Hold	1,290	–	–	﹤0.01%	4231
2018 Q2	$2.9K	Buy	+1,290	New	+$2.59K	﹤0.01%	4210

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BNP Paribas Financial Markets's ZOM Position: Q3 2020 in Review

BNP Paribas Financial Markets sold out of Zomedica Corp. (ZOM) in Q3 2020, closing a stake of 225 shares — an estimated $54 sold.

BNP Paribas Financial Markets first reported a position in ZOM in Q2 2018 and held it in 9 quarters. The position peaked at $3.42K in Q1 2019. 32 funds tracked by Wall St. Rank hold ZOM as of Q3 2020.

BNP Paribas Financial Markets reported no remaining Zomedica Corp. position as of Q3 2020 after selling out during the quarter.
BNP Paribas Financial Markets sold 225 Zomedica Corp. shares in Q3 2020, an estimated $54.
BNP Paribas Financial Markets first reported a position in Zomedica Corp. in Q2 2018 and held it in 9 quarters.
BNP Paribas Financial Markets's Zomedica Corp. position peaked at $3.42K in Q1 2019.
32 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.